Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
37.46
+0.60 (1.63%)
Feb 21, 2025, 4:00 PM EST - Market closed
Crinetics Pharmaceuticals Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$72.64
Upside
+93.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 4, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $55 | Hold → Strong Buy | Upgrades | $55 | +46.82% | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +116.23% | Jan 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $87 | Buy | Reiterates | $87 | +132.25% | Dec 16, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $70 → $74 | Strong Buy | Maintains | $70 → $74 | +97.54% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $69 → $81 | Strong Buy | Maintains | $69 → $81 | +116.23% | Nov 13, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $80 | Buy | Reiterates | $80 | +113.56% | Sep 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +140.26% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $69 | Strong Buy | Maintains | $60 → $69 | +84.20% | Aug 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $74 → $73 | Buy | Reiterates | $74 → $73 | +94.87% | Aug 9, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $47 → $54 | Buy | Maintains | $47 → $54 | +44.15% | Jul 9, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $97 | Buy | Maintains | $97 | +158.94% | Jul 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +60.17% | Jun 28, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $80 | Buy | Reiterates | $80 | +113.56% | Jun 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $55 → $74 | Buy | Maintains | $55 → $74 | +97.54% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +60.17% | Jun 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.